The science of the strip, told straight.

Most science pages are sales pages wearing glasses. This one has a simpler job: to explain how a dissolving strip actually works, what the research says so far, and where it goes quiet — plain English, hedges left in. What follows is what's known, what's suspected, and what nobody can honestly say yet.

How thin films are made

Every oral thin film begins as a liquid called a matrix: film-forming materials — pullulan, a fermentation-derived polysaccharide, and hypromellose, a plant-derived cellulose — the active ingredient, and the minor ingredients that shape taste and texture, blended until uniform. The liquid is then cast, meaning spread across a flat surface in one thin, even layer, the way a baker levels batter across a pan. Gentle, controlled drying follows: the water leaves, and what remains is a flexible film with the active ingredient held evenly through it. The sheet is cut into strips, each one a small, finished square of the same film. Few steps, few materials, and a finished film you can hold up to the light.

Absorption routes

Once a strip dissolves, its contents travel one of two roads. The first runs through the lining of the mouth — sublingual, under the tongue, or buccal, along the cheek — where thin tissue and abundant small vessels let some compounds begin entering circulation directly, bypassing the stomach altogether. The second is the familiar road: swallowed with saliva into the digestive tract, processed the way food is. Every strip sends part of its payload down each road; the split depends on the molecule's size and character, and on how the film is built.

Which brings up the honest question: do peptides survive digestion? Often, not well. Digestion exists to take chains of amino acids apart, and peptides are exactly that — chains of amino acids. This is the plain reason most peptide medications are given by injection. It is also the reason the mouth interests researchers: uptake that begins before swallowing sidesteps some of that gauntlet. How much of any given peptide takes the first road from a film is still being mapped, molecule by molecule, and we won't quote a percentage that hasn't been earned.

What's known, and what isn't yet

NAD+. The age-related decline of NAD+ is well documented, and human studies of NAD+ precursors show that levels can rise; what that means for cellular energy and healthy aging is the chapter research is still writing.*

BPC-157. Nearly everything known comes from preclinical work — lab and animal studies — and controlled human trials have not yet been published, which is why this peptide gets our most careful language, and never a promise.

GLP-1s. The most-studied of the three by a wide margin, with large human trials behind the approved injectable medications. Those findings belong to those specific products; compounded strip formats have not been through trials of their own, which is why ours travel with a provider.

A numbered references section will appear here once every citation has been verified — because a source you can't check is just a claim in a costume.